Skip to content
TrialScanner

NCT04170985

NeuroSeq: A Prospective Trial to Evaluate the Diagnostic Yield of Whole Genome Sequencing (WGS) in Adult Neurology

No phase registeredCompletedILMNLead

Registry record

Lead sponsor
Illumina, Inc.
Conditions
Neurologic Deficits; Neurologic Disorder; Neurologic Abnormalities
Primary completion
Jan 31, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04170985 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04170985: NeuroSeq: A Prospective... | TrialScanner